期刊文献+

MiR-122上调野生p53蛋白增强BEL-7402/5-FU细胞对5-氟尿嘧啶敏感性 被引量:2

MiR-122 Increases Sensitivity of BEL-7402/5-FU Cells to 5-fluorouracil via Up-regulation of Wild-type p53 Protein
暂未订购
导出
摘要 目的探讨MiRNA-122对肝癌耐药细胞株BEL-7402/5-FU的5-氟尿嘧啶敏感性的影响以及作用机制。方法构建miR-122及其阴性对照空载体稳定转染至BEL-7402/5-FU细胞中,Western blot检测未转染组,阴性载体转染组和miR-122转染组中与耐药相关的p53蛋白表达水平。用MTT法和流式细胞术检测三组细胞对5-氟尿嘧啶敏感性。结果 MiR-122转染组与未转染组,阴性载体转染组比较,野生型p53蛋白表达水平升高。流式细胞术检测,miR-122转染组的细胞凋亡率较未转染组和阴性载体转染组高。结论 miR-122能上调野生型p53蛋白表达,增加BEL-7402/5-FU细胞对5-氟尿嘧啶敏感性,从而成为治疗肝癌耐药治疗的一个方法。 Objective To investigate the influence and mechanism of miR-122 confer 5-FU sensitivity in BEL- 7402/5-FU cells. Methods MiR-122 and negative miRNA expression vectors were constructed and stably transfected into BEL-7402/5-FU cells. Western Blotting was used to detect Wild-type p53 ( wt-p53 ) protein expression. Drug sensitivity of the cells to 5-fluorouracil (5-FU) were analyzed with MTF and flow cytometry. Results Compared with negative miR- NA transfectants or untreated cells, protein expression level of wt-p53 in stable miR-122 transfectants were decreased. Flow cytometry results demonstrated that apoptosis rate increased in miR-122 transfected cells, compared with negative miRNA or untreated ceils. Conclution MiR-122 can specifically up-regulate the expression of wt-p53 in BEL-7402/5-FU cells, which increased ceils spontaneous apoptosis and sensitize cells to 5-FU. Therefore, miR-122 may be used as a potential therapy agent against human hepatoblastoma.
出处 《中南医学科学杂志》 CAS 2011年第6期640-642,658,共4页 Medical Science Journal of Central South China
关键词 微小RNA 野生型P53 BEL-7402/5-FU细胞 凋亡 5-氟尿嘧啶 miRNA wt-p53 BEL-7402/5-FU cells apoptosis 5-FU
  • 相关文献

参考文献8

  • 1李玉秀,林志彬,谭焕然.人肝癌Bel7402/5-FU耐药株多药耐药与凋亡关系的研究[J].中国药理学通报,2003,19(5):512-517. 被引量:7
  • 2Seiple L,Jaruga P,Dizdaroglu M,et al.Linking uracilbase excision repair and 5-fluorouracil toxicity in yeast. Nucleic Acids Research . 2006
  • 3Jin J,Huan M,Liu GT.Studies on the resistance mecha-nism of a 5-fluorouracil resistant human hepatocellularcarcinoma cell line Bel/5-FU. The Chinese YoungPharmacologists Symposium . 2002
  • 4I Sturm,AG Bosanquet,S Hermann,et al.Mutation of p53 and consecutive selective drug resistance in B-CLL occur as a consequence of prior DNA-damaging chemotherapy. Cell Death and Differentiation . 2003
  • 5Levin B,Amos C.Therapy of unresectable hepatocellular carcinoma. The New England Journal of Medicine . 1995
  • 6Kutay H,Bai S,Datta J, et al.Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. Journal of Cellular Biochemistry . 2006
  • 7Lou WY.Primary liver rumors.. Seminars in Surgical Oncology . 2000
  • 8Chang W T,Kang J J,Lee K Y,et al.Triptolide and chemotherapy cooperate in tumor cell apoptosis: a role for the p53 pathway. Journal of Biological Chemistry . 2001

二级参考文献1

共引文献6

同被引文献13

  • 1Bartel DP. microRNAs:Genomics,biogenesis,mechanism,and function[J].Cell,2004,(02):281-297.
  • 2Xie X,Lu J,Kulbokas EJ. Systematic discovery of regulatory motifs in human promoters and 3′UTRs by comparison of several mammals[J].Nature,2005,(7031):338-345.
  • 3Lewis BP,Burge CB,Bartel DP. Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J].Cell,2005,(01):15-20.doi:10.1016/j.cell.2004.12.035.
  • 4Engels BM,Hutvagner G. Principles and effects of microRNA-mediated post-transcriptional gene regulation[J].Oncogene,2006,(46):6188-6196.doi:10.1038/sj.onc.1209909.
  • 5Jopling CL,Norman KL,Sarnow P. Postivie and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122[J].Cold Spring Harbor Symposium on Quantitative Biology,2006.369-376.
  • 6Triboulet R,Mari B,Lin Y L. Suppression of microRNA silencing path way by HIV-1 during virus replication[J].Science,2007,(5818):1579-1582.doi:10.1126/science.1136319.
  • 7Eisnberg I,Alexander MS,Kunkel LM. miRNAs in normal and diseased skeletal muscle[J].Journal of Cellular and Molecular Medicine,2009,(01):2-11.doi:10.1111/j.1582-4934.2008.00524.x.
  • 8Calin GA,Croce CM. MicroRNA signatures in human cancers[J].Nature Reviews Cancer,2006,(11):857-866.
  • 9Girard M,Jacquemin E,Munnich A. miRNAs-122,a paradigm for the role of microRNAs in the liver[J].Hepatology,2008,(04):648-656.
  • 10Fabbri M,Ivan M,Cimmino A. Regulatory mechanisms of microRNAs involvement in cancer[J].Expert Opin Biol,2007,(07):1009-1019.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部